Bayer, the German drugmaker that bought U.S. seed company Monsanto earlier this year, announced on Thursday the sale of a number of businesses, around 12,000 job cuts and 3.3 billion euros ($3.8 billion) in impairments, Reuters reported.

Chief Executive Werner Baumann is under pressure to boost Bayer’s share price after a drop of more than 35 percent so far this year, dragged down by concern over more than 9,000 lawsuits it faces over the cancer-causing effect of Monsanto’s Roundup weed killer.

Sustainable Pulse Director, Henry Rowlands, commented on the shocking news on Thursday; “This just shows what happens when a company doesn’t do its homework before making a huge investment. Bayer will struggle to recover from the Monsanto fiasco and investors in the company are obviously now very concerned. The only way out of this mess for Bayer is to stop selling glyphosate-based herbicides.”